{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:30Z","timestamp":1786119330008,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>\n                    Breast cancer1-associated protein 1 (BAP-1)-inactivated melanocytic tumors are a group of familial or sporadic lesions with distinctive histology and molecular features. Inherited germline inactivating mutations in\n                    <jats:italic toggle=\"yes\">BAP1<\/jats:italic>\n                    have been associated with the development of multiple epithelioid melanocytic neoplasms resembling Spitz nevi and increased susceptibility for developing several malignancies, including uveal melanoma, cutaneous melanoma, renal cell carcinoma, mesothelioma, and other tumors. Cutaneous melanoma with loss of BAP1 expression is rare. We present a unique case of\n                    <jats:italic toggle=\"yes\">BAP1<\/jats:italic>\n                    -inactivated melanoma with anaplastic lymphoma kinase (\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    ) fusion arising in a pre-existing\n                    <jats:italic toggle=\"yes\">BAP1<\/jats:italic>\n                    -inactivated nevus in a 47-year-old female patient who presented with a dome-shaped red papule on the superior crus of the right antihelix. Histology revealed intradermal melanocytic proliferation with biphenotypic morphology. There was a proliferation of atypical melanocytes showing epithelioid features in the background of nevus. Mitotic figures were identified in the cytologically atypical component of the lesion. Mart-1\/Ki67 dual stain demonstrated a higher proliferation index in the larger epithelioid atypical cells, supporting the diagnosis of melanoma. Nuclear BAP-1 expression was lost in the larger atypical cells and associated nevoid cells. Preferentially expressed antigen in melanoma stain demonstrated focal positive staining in 20%\u201330% of the melanocytes. Immunostaining for B-Raf proto-oncogene, serine\/threonine kinase V600E was diffusely positive and ALK demonstrated patchy immunoreactivity in the melanocytic proliferation. Interphase fluorescence in situ hybridization studies showed gains at chromosome 6p25 (Ras responsive element binding protein 1) in the tumor cells. The comprehensive next-generation sequencing revealed\n                    <jats:italic toggle=\"yes\">B-Raf proto-oncogene, serine\/threonine kinase<\/jats:italic>\n                    <jats:italic toggle=\"yes\">V600E<\/jats:italic>\n                    mutation,\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    mutation,\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    fusion,\n                    <jats:italic toggle=\"yes\">BAP1<\/jats:italic>\n                    loss (copy number variation = 0.0, potentially germline), and loss of\n                    <jats:italic toggle=\"yes\">MAP2K7,<\/jats:italic>\n                    <jats:italic toggle=\"yes\">Von Hippel-Lindau tumor suppressor<\/jats:italic>\n                    <jats:italic toggle=\"yes\">, FGFR3, CDKN2A<\/jats:italic>\n                    , 19q, and\n                    <jats:italic toggle=\"yes\">telomerase reverse transcriptase<\/jats:italic>\n                    . The tumor was microsatellite stable with a low tumor mutational burden (5.76 mutations\/Mb). The tumor was completely excised with negative margins. The patient is doing well at 17 months follow-up with no signs of recurrence.\n                  <\/jats:p>","DOI":"10.1097\/dad.0000000000002925","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T09:00:20Z","timestamp":1738832420000},"page":"264-268","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["BRCA1-Associated Protein-1 Inactivated Melanoma Arising in a Pre-existing Nevus With ALK Fusion and Low Tumor Mutational Burden"],"prefix":"10.1097","volume":"47","author":[{"given":"Nada","family":"Shaker","sequence":"first","affiliation":[{"name":"Department of Pathology, University of California San Francisco, UCSF, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Phelps","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology, Icahn School of Medicine, Mount Sinai Medical Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Niedt","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology, Icahn School of Medicine, Mount Sinai Medical Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Sangueza","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pathology, Wake Forest Health, Winston-Salem, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishnan","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Bernhardt Laboratories (A Sonic Healthcare Anatomic Pathology Practice), Jacksonville, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankush","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Torres-Cabala","sequence":"additional","affiliation":[{"name":"Department of Dermatopathology, Division of Pathology\/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyu P.","family":"Aung","sequence":"additional","affiliation":[{"name":"Department of Dermatopathology, Division of Pathology\/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Prieto","sequence":"additional","affiliation":[{"name":"Department of Dermatopathology, Division of Pathology\/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine I.","family":"Dumur","sequence":"additional","affiliation":[{"name":"Bernhardt Laboratories (A Sonic Healthcare Anatomic Pathology Practice), Jacksonville, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Department of Pathology & Dermatology, The University of Nebraska Medical Center, Omaha, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"R1-20250314","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"R2-20250314","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/genes13010010","article-title":"Gene expression and mutational profile in BAP-1 inactivated melanocytic lesions of progressive malignancy from a patient with multiple lesions","volume":"13","author":"Zhou","year":"2021","journal-title":"Genes"},{"key":"R3-20250314","first-page":"239","article-title":"What genomics has taught me about melanocytic neoplasms","volume":"147","author":"Leboit","year":"2012","journal-title":"G Ital Dermatol Venereol"},{"key":"R4-20250314","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/cup.13488","article-title":"BAP1-deficient tumor\/nevus with germline aberration: a potential pitfall in assessing melanocytic neoplasms with single nucleotide polymorphism array","volume":"46","author":"Hedayat","year":"2019","journal-title":"J Cutan Pathol"},{"key":"R5-20250314","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PAS.0b013e318263648c","article-title":"Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes","volume":"37","author":"Busam","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R6-20250314","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/cup.12493","article-title":"Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome","volume":"42","author":"Maru\u0161i\u0107","year":"2015","journal-title":"J Cutan Pathol"},{"key":"R7-20250314","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.humpath.2014.10.015","article-title":"BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations","volume":"46","author":"Piris","year":"2015","journal-title":"Hum Pathol"},{"key":"R8-20250314","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Hum Genet"},{"key":"R9-20250314","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"R10-20250314","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cge.12501","article-title":"A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma","volume":"88","author":"Wadt","year":"2015","journal-title":"Clin Genet"},{"key":"R11-20250314","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/jmp4020012","article-title":"Analytical validation and clinical utilization of the oncomine comprehensive assay plus panel for comprehensive genomic profiling in solid tumors","volume":"4","author":"Dumur","year":"2023","journal-title":"J Mol Pathol"},{"key":"R12-20250314","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1200\/JCO.2011.41.2965","article-title":"Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations","volume":"30","author":"Wiesner","year":"2012","journal-title":"J Clin Oncol"},{"key":"R13-20250314","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","article-title":"Bap1 is a bona fide tumor suppressor: genetic evidence from mouse models carrying heterozygous germline Bap1 mutations","volume":"76","author":"Kadariya","year":"2016","journal-title":"Cancer Res"},{"key":"R14-20250314","first-page":"113","article-title":"Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy","volume":"48","author":"Wiesner","year":"2016","journal-title":"Pathology (Phila)"},{"key":"R15-20250314","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cge.12630","article-title":"Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases","volume":"89","author":"Rai","year":"2016","journal-title":"Clin Genet"},{"key":"R17-20250314","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/DAD.0000000000001217","article-title":"Melanoma with loss of BAP1 expression in patients with no family history of BAP1-associated cancer susceptibility syndrome: a case series","volume":"41","author":"Aung","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"R18-20250314","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/gcc.22424","article-title":"Germline BAP1 alterations in familial uveal melanoma","volume":"56","author":"Rai","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"R19-20250314","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS One"},{"key":"R20-20250314","first-page":"116","article-title":"Tumours associated with BAP1 mutations","volume":"45","author":"Murali","year":"2013","journal-title":"Pathology (Phila)"},{"key":"R21-20250314","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jaad.2018.09.014","article-title":"Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: results of a multicenter case-control study by the International Dermoscopy Society","volume":"80","author":"Y\u00e9lamos","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R22-20250314","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cll.2017.05.003","article-title":"Toward a molecular-genetic classification of spitzoid neoplasms","volume":"37","author":"Tetzlaff","year":"2017","journal-title":"Clin Lab Med"},{"key":"R23-20250314","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jaad.2018.05.005","article-title":"Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors","volume":"79","author":"Garfield","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R24-20250314","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jid.2019.12.031","article-title":"Integrating next-generation sequencing with morphology improves prognostic and biologic classification of spitz neoplasms","volume":"140","author":"Quan","year":"2020","journal-title":"J Invest Dermatol"},{"key":"R25-20250314","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/jid.2014.528","article-title":"BAP1 has a survival role in cutaneous melanoma","volume":"135","author":"Kumar","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R26-20250314","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/jnci\/djz005","article-title":"Targeted genomic profiling of acral melanoma","volume":"111","author":"Yeh","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"R27-20250314","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.3390\/cancers12102870","article-title":"Tumor microenvironment: implications in melanoma resistance to targeted therapy and immunotherapy","volume":"12","author":"Falcone","year":"2020","journal-title":"Cancers"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000002925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:03:57Z","timestamp":1786039437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000002925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002925","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]}}}